LONDON, UK – Scientists at the Universities of Liverpool and Oxford have unveiled a groundbreaking new therapy for multidrug-resistant gonorrhea, a discovery hailed by experts and tech-bro venture capitalists alike as a major victory for modern, consequence-free hookup culture. The treatment, which deploys the bacteria's own enzymes to trigger its destruction, reportedly minimizes damage to human cells while maximizing one's ability to remain utterly unburdened by foresight or latex.
“This isn’t just medicine; it’s a paradigm shift for human sexuality,” declared Dr. Chad Thundercock, Director of the Institute for Unfettered Carnal Expression, in an exclusive statement. “For too long, the specter of STI transmission has needlessly complicated what should be a frictionless, spontaneous exchange of bodily fluids. Now, we can finally achieve true sexual liberation, unencumbered by the tyranny of rubber or personal responsibility.”
Pharmaceutical companies are reportedly scrambling to fast-track the drug, with analysts predicting a massive surge in demand from the global population that consistently prioritizes immediate gratification over long-term health planning. Early projections show a significant uptick in sales among users of popular dating apps, whose entire business models often rely on the assumption that humans are inherently incapable of making responsible choices when presented with a glowing screen and a fleeting urge.
“Think of the efficiency gains,” gushed a spokesperson for a leading dating app, who requested anonymity to avoid being associated with basic human decency. “Our users can now connect, swipe, and interact with unprecedented speed. No more awkward conversations about protection, no more fumbling with foils. Just pure, unadulterated human connection, now with a convenient medical failsafe.”
Critics who pointed out that the root cause of rising STI rates might involve behavioral changes, not just medical ones, were quickly dismissed as “condom shaming fascists” whose dated moralizing stifled innovation and inhibited personal freedom. The new therapy is expected to integrate seamlessly into existing healthcare systems, allowing individuals to maintain their current lifestyles with minimal interruption, save for the occasional trip to the clinic for their quarterly reboot.
The breakthrough effectively streamlines the human experience, ensuring the only thing spread faster than delight is the next round of treatments.
